CD86 and neoplasm: Decreased anti-tumor immune responses in the tumor microenvironment have been associated with the CTLA-4/CD80,CD86 axis between immune cells and tumoral cells (Derakhshani, Hashemzadeh, Asadzadeh, and Shadbad 2021).